Completed

NCT Number: NCT01712542

Curcumin Bioavailability in Glioblastoma Patients

Measuring the bioavailability of orally administered curcumin in the tumors of glioblastoma patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Patient Harboring Glioblastoma That Will Undergo Surgery

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Neurosurgery, Johann Wolfgang Goethe-University

Frankfurt am Main, Hesse, 60528, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients harboring Glioblastoma
Patient will undergo surgery

Exclusion criteria

BMI > 30
Liver and Kidney Function so compromised that medication is prescribed

Treatment and study plan

Primary outcomes

Concentration of Curcumin in Glioblastoma

Time frame: At Tumor resection

At the time of surgery

Sponsors and collaborators

Lead sponsor

Johann Wolfgang Goethe University Hospital

Other

Registry information

Official study title

Measurement of Intratumoral Concentration of the Nontoxic Natural Compound Curcumin in Glioblastoma Patients

Important dates

Study start: 2012
Primary completion: 2013
Study completion: 2013
First posted: Oct 23, 2012
Registry last updated: Jun 4, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.